1 minute read
Jan. 17, 2022
Compound 3: a Vanin-1 Inhibitor
“compound 3”
vanin-1 pantetheinase inhibitor preclinical candidate for IBD from HTS + SBDD Journal of Medicinal Chemistry Pfizer, Cambridge, MA + Groton, CT
vanin-1 pantetheinase inhibitor preclinical candidate for IBD from HTS + SBDD Journal of Medicinal Chemistry Pfizer, Cambridge, MA + Groton, CT